COMMUNIQUÉS West-GlobeNewswire

TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
30/04/2024
Conference call to be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held tomorrow [...]
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
30/04/2024
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]
Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
30/04/2024
Visit the Codman Specialty Surgical booth to learn how the CereLink ICP Monitoring System provides patients with uncompromised advanced continuous ICP monitoring. PRINCETON, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- [...]
Clearmind Applies to Cease Being a Reporting Issuer in Canada
30/04/2024
Vancouver, Canada, April 30, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) (" Clearmind " or the “ Company ”), a clinical- stage biotech company focused on discovery and development [...]
CooperCompanies Announces Release Date for Second Quarter 2024
30/04/2024
SAN RAMON, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET. Following the release, [...]
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
30/04/2024
- Company to provide update on exciting new commercial agreement, as well as Phase 2 clinical trial in Spine and preclinical development program in Obesity - MELVILLE, N.Y., April 30, 2024 (GLOBE NEWSWIRE) -- [...]
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
30/04/2024
FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare [...]
Inari Medical Reports First Quarter 2024 Financial Results
30/04/2024
IRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
30/04/2024
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)
30/04/2024
In vivo data demonstrated efficacy of SCY-247 in mouse model of invasive candidiasis caused by Candida glabrata SCY-247 showed in vitro activity against a broad range of pathogenic fungi, including azole-resistant [...]
CVRx Reports First Quarter 2024 Financial and Operating Results
30/04/2024
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Silk Road Medical Reports First Quarter 2024 Financial Results
30/04/2024
SUNNYVALE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three [...]
Exagen to Announce First Quarter 2024 Results on May 13, 2024
30/04/2024
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on [...]
Merit Medical Reports Results for First Quarter Ended March 31, 2024
30/04/2024
Q1 2024 reported revenue of $323.5 million, up 8.7% compared to Q1 2023 Q1 2024 constant currency revenue* up 9.3% compared to Q1 2023 Q1 2024 constant currency revenue, organic* up 7.0% compared to Q1 2023 Q1 2024 GAAP [...]
Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024
30/04/2024
Management will also participate in four upcoming investor healthcare conferences SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision [...]
Stryker reports first quarter 2024 operating results
30/04/2024
Portage, Michigan, April 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2024: First Quarter Results Reported net sales increased 9.7% to $5.2 billion Organic net [...]
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference
30/04/2024
SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the RBC Capital Markets 2024 [...]
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine
30/04/2024
PITTSBURGH, April 30, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announces a collaboration with FluGen to bring a first-of-its-kind intranasal [...]
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
30/04/2024
-- Phase 3 Results from ENLIGHTEN 1 Trial of LYR-210 in Chronic Rhinosinusitis (CRS) Expected in May -- WATERTOWN, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company [...]

Pages